Labs / Assays & in vitro testing
Pangaea Oncology
Barcelona, Spain · panoncology.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Pangaea Oncology is a precision oncology company that provides molecular diagnostics, diagnostic assay validation, pre-clinical services, and research and development support. It works with patients and pharmaceutical and biotech partners in clinical care, translational oncology, and clinical trial support.
They take quote requests by email.
What they offer
Molecular diagnostics
Provides genomic, transcriptomic, and biomarker testing for tissue and liquid biopsy using NGS, IHC, FISH, RT-PCR, and nCounter to support diagnosis, treatment decisions, and trial eligibility.
DX platforms validation
Performs analytical and clinical validation of molecular diagnostic assays, including performance evaluation and workflow standardization for companion diagnostics.
Pre-clinical services
Combines molecular diagnostics with preclinical cancer research, including biomarker discovery, in vitro testing, patient-derived models, and organoid-based approaches.
Clinical trial lab services
Provides central laboratory services for global and multicenter trials, including real-time molecular screening, patient stratification, and biomarker analysis.
Research and development
Develops sponsored programs in liquid biopsy, multiplex assays, AI-supported clinical decision tools, immuno-oncology platforms, and lung cancer-related diagnostics.
What they work on
- Modalities
- solid tumors, liquid biopsy, tissue samples, blood-derived samples
- Species and models
- patient-derived primary cultures, fresh biopsies, malignant effusions, cell lines, drug-resistant cell lines, in vivo mouse models, 2D cell culture, 3D cell culture
- Assays and studies
- NGS, IHC, FISH, RT-PCR, nCounter, qPCR, gene expression profiling, transcriptomic signatures, TMB, MSI, mutation analysis, gene amplification testing, and 3 more
- Instruments and platforms
- NextSeq1000, TSO500 v2, nCounter, PROSIGNA (PAM50), MiSeq, IDYLLA, Rotor-Gene, QuantStudio, Ventana
- Scale and capacity
- more than 15 liquid biopsy clinical trials, over 300 cellular models
- Therapeutic areas
- precision oncology, breast cancer, endometrial cancer, colorectal cancer, lung cancer, non-small cell lung cancer, neuroendocrine tumors, immuno-oncology
- Turnaround
- POLE/POLD1 alterations in just a few days
- What to send
- tissue samples · liquid biopsy samples · blood-derived samples · fresh biopsies · malignant effusions
- Quality
- ISO 15189 (molecular diagnostics laboratory) · ENAC accreditation no. 750/LE1556 (quality management system) · IVDR Article 5(5) (in-house devices manufactured and used exclusively within the institution)
- Serves
- Europe, global and multicenter trials, Spain
Public records
- Ownership
- PANGAEA ONCOLOGY, S.A. · ES GLEIF
Similar labs. Allumiqs, Ambry Genetics, Avance Biosciences, Ohmx
Found in a contract services directory. Listing built from panoncology.com. Work here? Claim this listing.